Investing.com - Financial Markets Worldwide
Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Merck & Company Inc (0QAH)

London
Symbol
Exchange
Currency
MRKNYSEUSD
0QAHLondonUSD
MRKMexicoMXN
1MRKXMilanEUR
MRKXetraEUR
MRKTradeGateEUR
MRKFrankfurtEUR
MRKmBuenos AiresARS
MRCK34B3BRL
MRKViennaEUR
MRKUkraineUAH
MRKLimaUSD
Currency in USD
101.00
-1.00(-0.98%)
Closed
0QAH Scorecard
Full Analysis
Has raised its dividend for 14 consecutive years
Fair Value
Unlock Value
Day's Range
101.00101.00
52 wk Range
95.50134.62
Key Statistics
Edit
Bid/Ask
100.80 / 101.20
Prev. Close
101
Open
101
Day's Range
101-101
52 wk Range
95.5-134.62
Volume
25.65K
Average Volume (3m)
17.66K
1-Year Change
-3.44%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0QAH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Buy
Analysts Sentiment
Buy
Price Target
130.33
Upside
+29.54%
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 13
Net income is expected to grow this year
Unlock InvestingPro

Merck & Company Inc News & Analysis

Show more

Merck & Company Inc Company Profile

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. vIt has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications. It also has licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
71000
Market
United States

Compare 0QAH to Peers and Sector

Metrics to compare
0QAH
Peers
Sector
Relationship
P/E Ratio
21.0x−3.3x−0.7x
PEG Ratio
0.13−0.030.00
Price/Book
5.7x0.7x2.6x
Price / LTM Sales
4.0x1.4x3.2x
Upside (Analyst Target)
-229.9%43.2%
Fair Value Upside
Unlock36.7%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.79
Dividend Yield
3.21%
Industry Median 2.52%
Annualised payout
3.2400
Paid quarterly
5-Years Growth
-
Growth Streak
Unlock
More details

FAQ

What Is the Merck&Co (0QAH) Stock Price Today?

The Merck&Co stock price today is 101.00

What Stock Exchange Does Merck&Co Trade On?

Merck&Co is listed and trades on the London stock exchange.

What Is the Stock Symbol for Merck&Co?

The stock symbol for Merck&Co is "0QAH."

Does Merck&Co Pay Dividends? What’s The Current Dividend Yield?

The Merck & Company Inc dividend yield is 3.21%.

What Is the Merck&Co Market Cap?

As of today, Merck&Co market cap is 254.51B.

What is Merck&Co Earnings Per Share?

The Merck&Co EPS is 4.79.

What Is the Next Merck&Co Earnings Date?

Merck&Co will release its next earnings report on 03 Feb 2025.

From a Technical Analysis Perspective, Is 0QAH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.